Inventor
STEVEN A. BOYD
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium24%
A61KPreparations for medical, dental or toiletry purposes21%
C07DHeterocyclic compounds17%
C07HSugars7%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
12,173,018Penicillin-binding protein inhibitors202412,102,648Orally-bioavailable nucleoside analogs202412,084,445Broad-spectrum carbapenems202411,638,715Orally-bioavailable nucleoside analogs202311,566,001Hepatitis B capsid assembly modulators202311,332,485Penicillin-binding protein inhibitors202211,267,826Penicillin-binding protein inhibitors202211,247,965Hepatitis B capsid assembly modulators2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to VENATORX PHARMACEUTICALS INC (8)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VENATORX PHARMACEUTICALS INC | 8 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2024 |